FundedIQ

Funded Health Care Startups in Dubai

Across the 14 most recent Dubai health care rounds shown, the largest disclosed amount is Beaufond’s $100M on 2026-05-16, which dwarfs the next-largest dis…

Across the 14 most recent Dubai health care rounds shown, the largest disclosed amount is Beaufond’s $100M on 2026-05-16, which dwarfs the next-largest disclosed rounds ($15M by TruDoc on 2026-03-05, and $10M by Okadoc on 2022-11-10). Most disclosed deals cluster below $5M: the disclosed low end is $2M (Smileneo, 2021-04-07), while several rounds sit in the $3M range (Enhance Fitness $3M on 2021-09-14; Valeo $3M on 2021-06-15).

Timing-wise, activity is front-loaded into 2026: three disclosed rounds (Beaufond on 2026-05-16, Wellxa Health on 2026-04-03, TruDoc on 2026-03-05) fall within about 2.5 months, and five of the 14 entries are in 2022–2021. On stage labels, “Series Unknown” appears frequently (5 entries: Beaufond, meta[bolic], Endocare, Hoopla, and Vezeeta), alongside multiple undisclosed amounts (3 entries: meta[bolic], Endocare, Hoopla). All companies are listed in Dubai; however, cities are not fully uniform, with one entry explicitly Dubai, Dubai (UAE) and two entries listing Dubai without a second city field (Endocare and others).

Most recent rounds

14 shown

Related listings

Frequently asked

What stands out most in disclosed round size for Dubai health care in these rows?

Beaufond’s $100M (2026-05-16) is the clear outlier: it is far above the next-largest disclosed amount of $15M (TruDoc, 2026-03-05) and above the $10M disclosed round (Okadoc, 2022-11-10). Several other disclosed rounds cluster near the $2M–$5M range, including Smileneo’s $2M (2021-04-07) and Enhanc eFitness’s $3M (2021-09-14).

Are there temporal clusters, especially near the most recent dates?

Yes. In 2026, three disclosed rounds close within roughly 10 weeks: Beaufond ($100M, 2026-05-16), Wellxa Health ($500K, 2026-04-03), and TruDoc ($15M, 2026-03-05). Outside 2026, the dates spread across 2022–2021, including multiple $3M rounds in mid/late 2021 (Valeo $3M on 2021-06-15; Enhance Fitness $3M on 2021-09-14).

How common are missing amounts or unspecified stage labels in this list?

Undisclosed amounts appear in 3 of 14 rows: meta[bolic] (2026-02-05), Endocare (2025-05-08), and Hoopla (2024-06-10). “Series Unknown” shows up in 5 entries (Beaufond, meta[bolic], Endocare, Hoopla, Vezeeta), indicating that at least part of the segment lacks consistent deal metadata.

Which stage labels dominate, and how does that relate to disclosed deal sizes?

Stage labels are mixed, but “Series Unknown” is prominent (5 of 14 entries), and several of those also correspond to missing amounts (e.g., meta[bolic], Endocare, Hoopla are undisclosed). Among fully disclosed rounds, early-stage figures show up repeatedly in the lower range: Smileneo (Seed, $2M on 2021-04-07), Udenz (Series A, $5M on 2023-08-01), and Enhance Fitness (Series A, $3M on 2021-09-14).

Are there geographic concentration patterns within Dubai, or is it consistent across companies?

Every company is listed in Dubai, but the address formatting varies: many entries specify “Dubai, Dubai, United Arab Emirates” (e.g., Beaufond on 2026-05-16; Wellxa Health on 2026-04-03), while others list “Dubai, United Arab Emirates” (e.g., Endocare on 2025-05-08; Smileneo on 2021-04-07). There are no other countries or alternate cities shown in the 14-row set.

Which entries are the most recent and how do their disclosed amounts compare to older rounds?

The most recent row is Beaufond (2026-05-16) at $100M, followed by Wellxa Health (2026-04-03) at $500K and TruDoc (2026-03-05) at $15M. Compared with older disclosed rounds like Okadoc ($10M, 2022-11-10) and the $3M deals in 2021 (Valeo and Enhance Fitness), the 2026 disclosed amounts range from the sub-$1M floor to the $100M outlier.

Free · Every Monday

Know which startups just got funded. Every week.

Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.

Free. Sent every Monday. Unsubscribe anytime.